BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

507 related articles for article (PubMed ID: 30006483)

  • 1. LTBP2 is secreted from lung myofibroblasts and is a potential biomarker for idiopathic pulmonary fibrosis.
    Enomoto Y; Matsushima S; Shibata K; Aoshima Y; Yagi H; Meguro S; Kawasaki H; Kosugi I; Fujisawa T; Enomoto N; Inui N; Nakamura Y; Suda T; Iwashita T
    Clin Sci (Lond); 2018 Jul; 132(14):1565-1580. PubMed ID: 30006483
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reversion of in vivo fibrogenesis by novel chromone scaffolds.
    Kim HS; Yoon YM; Meang MK; Park YE; Lee JY; Lee TH; Lee JE; Kim IH; Youn BS
    EBioMedicine; 2019 Jan; 39():484-496. PubMed ID: 30611717
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Human antigen R promotes lung fibroblast differentiation to myofibroblasts and increases extracellular matrix production.
    Al-Habeeb F; Aloufi N; Traboulsi H; Liu X; Nair P; Haston C; Azuelos I; Huang SK; White ES; Gallouzi IE; Di Marco S; Eidelman DH; Baglole CJ
    J Cell Physiol; 2021 Oct; 236(10):6836-6851. PubMed ID: 33855709
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Andrographolide ameliorates bleomycin-induced pulmonary fibrosis by suppressing cell proliferation and myofibroblast differentiation of fibroblasts via the TGF-β1-mediated Smad-dependent and -independent pathways.
    Li J; Feng M; Sun R; Li Z; Hu L; Peng G; Xu X; Wang W; Cui F; Yue W; He J; Liu J
    Toxicol Lett; 2020 Mar; 321():103-113. PubMed ID: 31706003
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lung myofibroblasts are characterized by down-regulated cyclooxygenase-2 and its main metabolite, prostaglandin E2.
    Gabasa M; Royo D; Molina-Molina M; Roca-Ferrer J; Pujols L; Picado C; Xaubet A; Pereda J
    PLoS One; 2013; 8(6):e65445. PubMed ID: 23755232
    [TBL] [Abstract][Full Text] [Related]  

  • 6. LncRNA GAS5 suppresses TGF-β1-induced transformation of pulmonary pericytes into myofibroblasts by recruiting KDM5B and promoting H3K4me2/3 demethylation of the PDGFRα/β promoter.
    Wang Y; Chen D; Xie H; Zhou S; Jia M; He X; Guo F; Lai Y; Tang XX
    Mol Med; 2023 Mar; 29(1):32. PubMed ID: 36918759
    [TBL] [Abstract][Full Text] [Related]  

  • 7. EZH2 enhances the differentiation of fibroblasts into myofibroblasts in idiopathic pulmonary fibrosis.
    Xiao X; Senavirathna LK; Gou X; Huang C; Liang Y; Liu L
    Physiol Rep; 2016 Sep; 4(17):. PubMed ID: 27582065
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transforming growth factor (TGF)-β1-induced miR-133a inhibits myofibroblast differentiation and pulmonary fibrosis.
    Wei P; Xie Y; Abel PW; Huang Y; Ma Q; Li L; Hao J; Wolff DW; Wei T; Tu Y
    Cell Death Dis; 2019 Sep; 10(9):670. PubMed ID: 31511493
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cartilage oligomeric matrix protein in idiopathic pulmonary fibrosis.
    Vuga LJ; Milosevic J; Pandit K; Ben-Yehudah A; Chu Y; Richards T; Sciurba J; Myerburg M; Zhang Y; Parwani AV; Gibson KF; Kaminski N
    PLoS One; 2013; 8(12):e83120. PubMed ID: 24376648
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Arsenic trioxide inhibits transforming growth factor-β1-induced fibroblast to myofibroblast differentiation in vitro and bleomycin induced lung fibrosis in vivo.
    Luo F; Zhuang Y; Sides MD; Sanchez CG; Shan B; White ES; Lasky JA
    Respir Res; 2014 Apr; 15(1):51. PubMed ID: 24762191
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of WNT5A in Idiopathic Pulmonary Fibrosis and Its Control by TGF-β and WNT7B in Human Lung Fibroblasts.
    Newman DR; Sills WS; Hanrahan K; Ziegler A; Tidd KM; Cook E; Sannes PL
    J Histochem Cytochem; 2016 Feb; 64(2):99-111. PubMed ID: 26538547
    [TBL] [Abstract][Full Text] [Related]  

  • 12. miR-145 regulates myofibroblast differentiation and lung fibrosis.
    Yang S; Cui H; Xie N; Icyuz M; Banerjee S; Antony VB; Abraham E; Thannickal VJ; Liu G
    FASEB J; 2013 Jun; 27(6):2382-91. PubMed ID: 23457217
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of RUNX1 blocks the differentiation of lung fibroblasts to myofibroblasts.
    Dubey S; Dubey PK; Umeshappa CS; Ghebre YT; Krishnamurthy P
    J Cell Physiol; 2022 Apr; 237(4):2169-2182. PubMed ID: 35048404
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Curdione ameliorates bleomycin-induced pulmonary fibrosis by repressing TGF-β-induced fibroblast to myofibroblast differentiation.
    Liu P; Miao K; Zhang L; Mou Y; Xu Y; Xiong W; Yu J; Wang Y
    Respir Res; 2020 Feb; 21(1):58. PubMed ID: 32075634
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Novel differences in gene expression and functional capabilities of myofibroblast populations in idiopathic pulmonary fibrosis.
    Walsh SM; Worrell JC; Fabre A; Hinz B; Kane R; Keane MP
    Am J Physiol Lung Cell Mol Physiol; 2018 Nov; 315(5):L697-L710. PubMed ID: 30091381
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bone morphogenetic protein 4 inhibits pulmonary fibrosis by modulating cellular senescence and mitophagy in lung fibroblasts.
    Guan R; Yuan L; Li J; Wang J; Li Z; Cai Z; Guo H; Fang Y; Lin R; Liu W; Wang L; Zheng Q; Xu J; Zhou Y; Qian J; Ding M; Luo J; Li Y; Yang K; Sun D; Yao H; He J; Lu W
    Eur Respir J; 2022 Dec; 60(6):. PubMed ID: 35777761
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CCN5 overexpression inhibits profibrotic phenotypes via the PI3K/Akt signaling pathway in lung fibroblasts isolated from patients with idiopathic pulmonary fibrosis and in an in vivo model of lung fibrosis.
    Zhang L; Li Y; Liang C; Yang W
    Int J Mol Med; 2014 Feb; 33(2):478-86. PubMed ID: 24276150
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An inhibitor of NADPH oxidase-4 attenuates established pulmonary fibrosis in a rodent disease model.
    Jarman ER; Khambata VS; Cope C; Jones P; Roger J; Ye LY; Duggan N; Head D; Pearce A; Press NJ; Bellenie B; Sohal B; Jarai G
    Am J Respir Cell Mol Biol; 2014 Jan; 50(1):158-69. PubMed ID: 23977848
    [TBL] [Abstract][Full Text] [Related]  

  • 19. TGF-β1-induced miR-424 promotes pulmonary myofibroblast differentiation by targeting Slit2 protein expression.
    Huang Y; Xie Y; Abel PW; Wei P; Plowman J; Toews ML; Strah H; Siddique A; Bailey KL; Tu Y
    Biochem Pharmacol; 2020 Oct; 180():114172. PubMed ID: 32712053
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MicroRNA-27a-3p Is a Negative Regulator of Lung Fibrosis by Targeting Myofibroblast Differentiation.
    Cui H; Banerjee S; Xie N; Ge J; Liu RM; Matalon S; Thannickal VJ; Liu G
    Am J Respir Cell Mol Biol; 2016 Jun; 54(6):843-52. PubMed ID: 26600197
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.